Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03344757 · ClinicalTrials.gov registry record · NA
Health Gatherings - For Your Health After Cancer
A NA study of Urogenital Neoplasms and Prostate Neoplasm, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 188
- Enrollment target
- 2
- Study locations
NCT03344757: Completed NA study of Urogenital Neoplasms and Prostate Neoplasm, sponsored by University of Miami.
NCT03344757 is a NA study of Urogenital Neoplasms and Prostate Neoplasm that has completed, run by University of Miami. The registered enrollment target is 188 participants, below the 285-participant average among 11 other Urogenital Neoplasms trials with a reported enrollment target (34% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03344757, a NA study of Urogenital Neoplasms and Prostate Neoplasm, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to look at the effects of a 10-week stress management in-person group program. The program will study emotions, stress, and stress management techniques (such as relaxation and coping techniques) on quality of life, distress, depression, and physical health in Spanish- speaking, Hispanic/Latino men diagnosed with Prostate Cancer (PC).
Primary Outcome
Symptom Burden will be measured using the 5-item sexual domain of the Expanded Prostate Cancer Index Composite (EPIC) - Short Form (EPIC-S). All items are transformed to a 0-100 scale and averaged to calculate the domain summary scores, where higher scores indicate better functioning and less bother.
Conditions Studied
Interventions
- BEHAVIORAL Cultural CBSM
- BEHAVIORAL Standard CBSM
Study Locations (2)
Florida
- University of Miami - Miami
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2017-10-05 |
| Est. Completion | 2024-08-01 |
| Phase | NA |
What the finished NCT03344757 record still lists
NCT03344757 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 285-participant average among 11 other Urogenital Neoplasms trials with a reported enrollment target (34% lower).
The record links to 6 conditions, with Urogenital Neoplasms appearing as the primary indexed condition, and to 2 interventions - of which Cultural CBSM is the first listed.
NCT03344757 reports a single indexed study location in Florida, Illinois.
Frequently Asked Questions
What is clinical trial NCT03344757 about?
NCT03344757 is a clinical study titled "Health Gatherings - For Your Health After Cancer". The purpose of this study is to look at the effects of a 10-week stress management in-person group program. The program will study emotions, stress, and stress management techniques (such as relaxation and coping techniques) on quality of life, distress, depression, and physical health in Spanish- s...
What is the current status of trial NCT03344757?
This trial is currently completed. It is a NA study. The enrollment target is 188 participants. The study started on 2017-10-05. Estimated completion is 2024-08-01.
What conditions does trial NCT03344757 study?
This clinical trial studies the following conditions: Urogenital Neoplasms, Prostate Neoplasm, Genital Diseases, Male, Prostatic Diseases, Genital Neoplasms, Male.
What interventions are being tested in trial NCT03344757?
The interventions under investigation include: Cultural CBSM (BEHAVIORAL), Standard CBSM (BEHAVIORAL).
Who is sponsoring clinical trial NCT03344757?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03344757 being conducted?
This trial has 2 study locations across Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urogenital Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03344757's enrollment target sits among peer trials
188 5th of 11 higher than 7 of 11 other Urogenital Neoplasms trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urogenital Neoplasms trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients
COMPLETED · NA
-
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetate, Olaparib, or 177Lu-PSMA-617
RECRUITING · Phase 1
-
A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
RECRUITING
-
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies
RECRUITING · Phase 1
-
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI